• Profile
Close

Early evaluation of response using 18F-FDG PET influences management in gastrointestinal stromal tumor patients treated with neoadjuvant imatinib

The Journal of Nuclear Medicine Feb 07, 2018

Farag S, et al. - The experts undertook this study to examine whether early evaluation of response affects treatment decisions in gastrointestinal stromal tumor (GIST) patients treated with neoadjuvant intent. In GIST patients harboring the non–KIT exon 11 mutation, performing 18F-FDG PET for early evaluation of response often resulted in a change of management. This ought to be considered the standard of care in GIST patients treated with neoadjuvant intent.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay